These Medications May Beat Migraines
Migraines can be such a headache. Luckily, many migraine treatments work.
Migraine Patients May Face Facial Paralysis Risk
Migraine patients may have another headache to worry about. Migraines may be connected to a treatable type of facial paralysis.
Migraines Not Tied to Breast Cancer
They're painful and can put patients out of commission for hours or even days, but migraines aren't likely associated with breast cancer — despite past research that suggested they might be.
Migraines Associated With Parkinson’s
Migraines can make daily tasks a challenge. But people who get intense migraines may also face a heightened risk of Parkinson’s disease later in life.
Migraines Might Affect Stroke Risk
People with a history of migraines may have to take steps to avoid another serious health problem, according to new research.
Stopping Migraines Before They Start
Nursing oneself back from a migraine is one thing. Preventing those dizzying, painful headaches from happening altogether is another matter.
FDA Approves Topamax for Migraine Prevention in Adolescents
Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The medication is taken on a daily basis to reduce the frequency of migraine headaches.
Mood-Stabilizing Rx Tied to Lower Risk of Some Cancers
Mood-stabilizing medications are used to treat mental or neurological conditions, but a new study suggested that one of these medications might have an unexpected effect — preventing cancer.
Reasons Why Your Head Hurts
Knowing the cause of a headache helps people decide what course to take to get rid of that headache. So, here’s a list of possible explanations for a headache.
Brain Scans May Be Too Common for Headaches
When headaches reoccur, patients may worry that something serious is at play. Doctors might use brain scans on these patients to look for trouble, but this practice may be overused, says a new study.